The company in question is, Sanofi (NYSE:SNY) currently with a stock price of 39.38 (0.51% today). The market cap for Sanofi is 98818.99, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Sanofi is 51.67. Currently Sanofi is trading with a P/E of 22.14, and a forward P/E of 13.15. Average volume for Sanofi is 2338.97 and so far today it is 1086700.
Performance in the last year for Sanofi has been -15.30%. For EPS growth, Sanofi has seen a growth of 4.10%, and is looking to grow in the next year to -1.80%. More long term stats show that EPS growth has been -4.40% over the last five years and could be 6.40% for the next five years. Sanofi has seen sales growth quarter over quarter at -4.40%, with EPS growth quarter over quarter at -9.90%. The 20-day simple moving average is -3.08%, with the 200-day simple moving average coming to -1.68%.
Since the IPO date for Sanofi on the 7/1/2002, Sanofi has seen performance year to date to be -3.78%. With Sanofi trading at 39.38, the dividend yield is 4.22%, and the EPS is 1.78.
So could Sanofi, be undervalued? Well as said before P/E is 22.14. The PEG is 3.46, P/S is 2.59 and the P/B is at 1.67. The P/cash is 14.22, with P/free cash flow at *TBA.
Sanofi ability to deal with debt shows that the current ratio is 1.5, and the quick ratio is 1. This is with long term debt/equity at 0.27, and total debt/equity at 0.32.
In terms of margins, Sanofi has a gross margin of 68.90%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for Sanofi is *TBA. Return on assets come to *TBA with return on investment coming to 6.50%.
Insider ownership for Sanofi, is at 16.40% and institutional ownership comes to 10.30%. Outstanding shares are at 2509.37. While shares float is 2304.07. The float short is currently 0.12%, and short ratio is 1.14.